Research & Development

Our research

All Deversify’s products generate consumer health data and our goal is to be the leading provider of consumer health products for improved fact-based wellbeing globally.

Measuring is an important start, but precision health is an even more powerful concept when paired with educational tools. To empower consumers in understanding their own health even better, we provide apps that inspire and enable daily monitoring of biomarkers and food purchase/dietary intake, to detect meta trends regarding changes in individual health and wellbeing.

Deversify will collect, analyse, and perform research on data generated from our products. New knowledge will be re-communicated both to the consumers for increased product value as well as to the academia research community.

Ongoing development projects

Deversify innovate, develop, and commercialise mobile electronic breathalyzers for the consumers market as well as for businesses and health care providers.

We have created a general breath analysis platform – both hardware and software – because we believe regular, repeatable, accurate measurements are key to understanding each individual’s nutritional needs and metabolism.

We also believe in education. Therefore, we – beyond the hardware and the general breath analysis platform – invest in and acquire knowledge platforms and education programmes centred around personalised nutrition and wellbeing.

To further support the process of understanding individual health and lifestyle changes, we develop and provide tailor-made education of how to reverse metabolic unhealth to becoming metabolic health. This includes lectures, seminars, and one-to-one coaching through world-class education.

Our vision is that everyone should understand their own health.

Abdomatic

The metabolic unhealth that can be related to the gut is growing rapidly. Many people suffer from symptoms such as Irritable Bowel Syndrome (IBS) and lactose intolerance. This can be due to Small Intestinal Bacterial Overgrowth (SIBO) and is detectable in exhaled breath.

Abdomatic is a breathalyzer for diagnosing and monitoring of SIBO in exhaled breath. It is an innovation emanating from a clinical need from health care providers to respond to an increasing demand among patients/consumers to address metabolic unhealth relating to the gut. There is a growing need to apply precision health among practitioners to capture idiosyncratic symptoms.

Abdomatic will also be provided directly to the consumer market to empower individuals to monitor their metabolic health.

The Sugarfree Day 2024 a success!

2024.10.12

Wrapping up this year's Sugarfree Day, we conclude we had a sold out A-huset and many more online. The adjacent exhibition displayed all aspects of metabolic health initiatives, including our own Metabolic Screening, Acetrack and book sales (that sold out!)

Ringing the bell at Nasdaq!

2024.09.06

What a day for us all - thanks for everyone involved throughout the years!

Distribution agreement with Belgian digital pharmacy Newpharma

2024.08.20

Uppsala, 20240820 — Deversify Health AB (publ) ("Deversify"), which was recently listed on Nasdaq First North through a reverse acquisition, has signed a distribution agreement with Belgian pharmacy chain Newpharma SRL ("Newpharma") and their subsidiary Smart Value Distribution SRL for resale of Acetrack in central Western Europe. As far as resellers are concerned, Deversify currently only has such dealers in Sweden and offers Acetrack in the rest of Europe and the world exclusively through its own channels. The agreement with Newpharma means that two new milestones are achieved: part resale in central Europe and part distribution to end customers through digital and physical pharmacies. Newpharma is a fast-growing pharmacy chain with e-commerce in France, Belgium, the Netherlands, Luxembourg, Germany, Austria and Switzerland and was among other things voted France's best e-pharmacy in 2023. Their distribution company also delivers to other pharmacies around the region, in in most cases physical pharmacies. Newpharma also has a close connection with Yooboo, which is a Belgian opinion leader around the importance of lifestyle changes. "The fact that we are starting to find local sales channels and logistics partners out in continental Europe is a good sign that the demand for solutions such as Acetrack offers is rising," says Anders Murman, CEO of Deversify. "The fact that it also comes from an actor such as Newpharma, with a modern approach to lifestyle changes and which tries to change how the pharmacy's role in society can become more holistic, is gratifying as it is completely in line with Deversify's view of how health improvements can be achieved without necessarily always rely on medicine."

SPA for reverse take-over of Euroafrica Digital Ventures announced

2024.02.29

Read more in the press release segment (in Swedish)